PubMed Health⌕ Search

PubMed · 17015078

Neuroimaging methods in affective neuroscience: selected methodological issues.

Abstract

A current goal of affective neuroscience is to reveal the relationship between emotion and dynamic brain activity in specific neural circuits. In humans, noninvasive neuroimaging measures are of primary interest in this endeavor. However, methodological issues, unique to each neuroimaging method, have important implications for the design of studies, interpretation of findings, and comparison across studies. With regard to event-related brain potentials, we discuss the need for dense sensor arrays to achieve reference-independent characterization of field potentials and improved estimate of cortical brain sources. Furthermore, limitations and caveats regarding sparse sensor sampling are discussed. With regard to event-related magnetic field (ERF) recordings, we outline a method to achieve magnetoencephalography (MEG) sensor standardization, which improves effects' sizes in typical neuroscientific investigations, avoids the finding of ghost effects, and facilitates comparison of MEG waveforms across studies. Focusing on functional magnetic resonance imaging (fMRI), we question the unjustified application of proportional global signal scaling in emotion research, which can greatly distort statistical findings in key structures implicated in emotional processing and possibly contributing to conflicting results in affective neuroscience fMRI studies, in particular with respect to limbic and paralimbic structures. Finally, a distributed EEG/MEG source analysis with statistical parametric mapping is outlined providing a common software platform for hemodynamic and electromagnetic neuroimaging measures. Taken together, to achieve consistent and replicable patterns of the relationship between emotion and neuroimaging measures, methodological aspects associated with the various neuroimaging techniques may be of similar importance as the definition of emotional cues and task context used to study emotion.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Markus Junghöfer, Peter Peyk, Tobias Flaisch, Harald T Schupp. 2006. Neuroimaging methods in affective neuroscience: selected methodological issues.. https://doi.org/10.1016/s0079-6123(06)56007-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗